ClinicalTrialsFinder
RecruitingNot ApplicableNCT03897270

Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects

Photoacoustic Imaging of Human Breast

Sponsor

Roswell Park Cancer Institute

Enrollment

400 participants

Start Date

Oct 25, 2018

Study Type

INTERVENTIONAL

Conditions

Breast CarcinomaHealthy Subject

Summary

This trial studies photoacoustic imaging of the breast in patients with breast cancer and healthy subjects. Dense breasts typically reduce the sensitivity of a mammography and also is associated with a higher risk of breast cancer. Photoacoustic tomography combines light and sound to provide more information about breast tissue.

Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria1

  • Women with clinically suspicious or confirmed breast cancer masses (that have not been surgically removed) and will/have already undergo/undergone breast magnetic resonance imaging (MRI).

Exclusion Criteria8

  • Pregnant women (there are no known risks to these procedures, but any unforeseen risks are as yet undetermined, so pregnant women will be excluded by means of a verbal confirmation at time of screening).
  • Women who have had breast implants in the previous 6 months.
  • Women who have had lumpectomy
  • Adults unable to consent.
  • Individuals who are not yet adults (infants, children, teenagers).
  • Pregnant women.
  • Prisoners.
  • There is no direct benefit of the study to any subject either non-English or English speaker. To facilitate the consent process, we will exclude non-English speaking subjects.

Interventions

PROCEDUREPhotoacoustic Imaging

Undergo photoacoustic imaging of the breast

Locations(1)

Roswell Park Cancer Institute

Buffalo, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03897270

Related Trials

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

NCT06418204467 locations

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

NCT059415204 locations

The Vanguard Study: Testing a New Way to Screen for Cancer

NCT0699589836 locations

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

NCT0618475011 locations

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

NCT061953063 locations